This hypothesis is further supported by the previously demonstrated ability of PODXL to form complex with ezrin in breast and prostate cancer cells in vitro, thereby inducing phosphorylation of ezrin and changes in its subcellular location, in turn leading to an increased migration and invasion [21]. Here, PODXL is linked to prostate cancer.